Tumor budding is a significant indicator of a poor prognosis in lung squamous cell carcinoma patients
Open Access
- 27 August 2012
- journal article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 6 (5), 937-943
- https://doi.org/10.3892/mmr.2012.1048
Abstract
Lung cancer is a leading cause of cancer mortality worldwide and patients occasionally develop local recurrence or distant metastasis soon after curative resection. Reports of new therapeutic strategies for lung squamous cell carcinoma (SqCC) are extremely rare, while selective anticancer therapy has been reported for lung adenocarcinoma. The aim of this study was to identify clinicopathological prognostic factors for SqCC. We analyzed tumor budding and infiltrative patterns (INF) in 103 cases of surgically-resected SqCC. Tumor infiltrative patterns were classified into three groups (INFa, b and c) and INFc was infiltrative growth at the tumor invasive front. The cases with an INFc component [INFc(+)]were significantly associated with venous invasion (P=0.014) and the scirrhous stromal type (P<0.001). The overall survival rate of patients with INFc(+) was significantly lower than that of patients without the INFc component [INFc(-); P=0.003]. Tumor budding was defined as a single cancer cell or a small nest of up to four cancer cells within stromal tissue. The cases with tumor budding [Bud(+)] were significantly associated with lymph node metastasis (P=0.001), lymphatic invasion (P=0.002), INFc(+) (P<0.001) and the scirrhous stromal type (P=0.014). Patients with the Bud(+) type had a lower overall survival rate than patients with the Bud(-) type (P<0.001). Multivariate analysis demonstrated that tumor budding [hazard ratio (HR), 2.766; 95% confidence interval (CI), 1.497-5.109] and lymph node metastasis (HR, 1.937; 95% CI, 1.097-3.419) were independent predictors of mortality. In conclusion, tumor budding is a significant indicator of a high malignant potential and poor prognosis in SqCC of the lung.Keywords
This publication has 27 references indexed in Scilit:
- Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinomaJournal of Oral Pathology & Medicine, 2011
- Tumor Budding as a Strong Prognostic Indicator in Invasive Ampullary AdenocarcinomasThe American Journal of Surgical Pathology, 2010
- Histopathologic Features of the Tumor Budding in Adenocarcinoma of the Lung: Tumor Budding As an Index to Predict the Potential AggressivenessJournal of Thoracic Oncology, 2010
- Impact of tumor infiltration pattern into the surrounding tissue on prognosis of the subserosal gastric cancer (pT2b)European Journal of Surgical Oncology, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Pemetrexed versus Gefitinib versus Erlotinib in Previously Treated Patients with Non-Small Cell Lung CancerThe Korean Journal of Internal Medicine, 2010
- Customized Treatment in Non-Small-Cell Lung Cancer Based on EGFR Mutations and BRCA1 mRNA ExpressionPLOS ONE, 2009
- Growth pattern and prognosis of gastric cancer invading the subserosaJournal of Surgical Oncology, 1994
- Prognostic value of depth and pattern of stomach wall invasion in patients with an advanced gastric carcinomaSeminars in Surgical Oncology, 1994
- Prognostic value of tumor “budding” in patients with colorectal cancerDiseases of the Colon & Rectum, 1993